{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T20:33:20Z","timestamp":1794688400461,"version":"4.9.1"},"reference-count":15,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"vor","delay-in-days":8902,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1987,9,10]]},"abstract":"<jats:p>Spiramycin, a macrolide antibiotic, has been advocated for the treatment of cryptosporidiosis. The disease most commonly occurs in patients with AIDS and can be debilitating, as diarrhea and malnutrition may be contributing factors in the death of these patients. Until recently, treatment for cryptosporidiosis has been largely symptomatic. Response rates with drug therapy such as metronidazole, quinidine\u2010clindamycin, and pentamidine have been extremely poor. Although response to spiramycin has appeared promising, there have been several reported cases of treatment failure. Further investigation with the agent is advocated to determine its role in the treatment of cryptosporidiosis.<\/jats:p>","DOI":"10.1002\/j.1875-9114.1987.tb04049.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T14:10:18Z","timestamp":1450275018000},"page":"188-190","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Spiramycin in the Treatment of Cryptosporidiosis"],"prefix":"10.1002","volume":"7","author":[{"given":"Alison M.","family":"Pilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Rybak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. H.","family":"Chandrasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/6.3.313"},{"key":"e_1_2_1_3_2","first-page":"117","article-title":"Update: treatment of cryptosporidiosis in patients with acquired immunodeficiency syndrome (AIDS)","volume":"33","author":"Centers for Disease Control","year":"1984","journal-title":"MMWR"},{"key":"e_1_2_1_4_2","first-page":"507","article-title":"Update on acquired immune deficiency syndrome (AIDS) \u2014 United States","volume":"31","author":"Centers for Disease Control.","year":"1982","journal-title":"MMWR"},{"key":"e_1_2_1_5_2","first-page":"539","article-title":"Treatment of infectious complications of acquired immunodeficiency syndrome","volume":"4","author":"Furio MM","year":"1985","journal-title":"Clin Pharm"},{"key":"e_1_2_1_6_2","first-page":"589","article-title":"Cryptosporidiosis: assessment of chemotherapy of males with acquired immunodeficiency syndrome (AIDS)","volume":"31","author":"Centers for Disease Control.","year":"1982","journal-title":"MMWR"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1983.00350120059015"},{"key":"e_1_2_1_8_2","volume-title":"The Merck index","author":"Windholz M","year":"1983"},{"key":"e_1_2_1_9_2","first-page":"289","article-title":"Spiramycin therapeutic use in man [translation]","volume":"58","author":"Kernbaum S","year":"1982","journal-title":"Sem Hop Paris"},{"key":"e_1_2_1_10_2","first-page":"986","article-title":"Chemotherapy of gonorrhea: a review of current status","volume":"107","author":"Sim SK","year":"1972","journal-title":"Can Med Assoc J"},{"key":"e_1_2_1_11_2","first-page":"129","article-title":"Preventing and treating toxoplasmosis","volume":"13","author":"Marcus LC","year":"1983","journal-title":"Drug Ther"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1978.03910050026006"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197405162902003"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-2-202"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-2-205"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1984.33.1065"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1987.tb04049.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1987.tb04049.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1875-9114.1987.tb04049.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:39:45Z","timestamp":1761053985000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.1987.tb04049.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,9,10]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1987,9,10]]}},"alternative-id":["10.1002\/j.1875-9114.1987.tb04049.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1875-9114.1987.tb04049.x","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,9,10]]},"assertion":[{"value":"2012-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}